Biohaven Ltd BHVN Q1 2026 Earnings Wider Loss Than Expected as PreRevenue Biotech Advances Pipeline ALGS Q1 2026 Earnings NarrowerThanExpected Loss as Aligos Therapeutics Advances Pipeline MDU Q1 2026 Earnings EPS Misses Estimates but Stock Gains 15 RCUS Q1 2026 Earnings EPS Miss Highlights Ongoing RD Investment Challenges BCPC Q1 2026 Earnings EPS Misses Estimates Stock Slightly Down Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development